ClearFlow Names Michael Elniski VP of Global Sales

May 21, 2019 |

2 min read

ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales.

ANAHEIM, Calif,--(BUSINESS WIRE)-- ClearFlow Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales.

Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized for building sales organizations that consistently over-achieve sales goals. He brings to ClearFlow a rich expertise in developing commercial strategy and execution focused on competitive and disruptive medical device solutions.

“Michael has had a distinguished career to date, with major corporations in his wake, including 16 years at Edwards rising through the ranks from sales professional to executive leadership positions there and at Merit,” said Paul Molloy, CEO of ClearFlow. “His sales and commerce credentials are truly impressive but his work ethic, character and personality are what sealed our attraction to him. Michael is hard working, organized, disciplined and focused and brings years of medical device commercialization experience to ClearFlow. It’s a great fit and we look forward to reaping the benefits of his skills and expertise as we continue to grow and develop a world class sales organization befitting our innovative and disruptive science and technology.”

ClearFlow is the manufacturer of the PleuraFlow^® Active Clearance Technology^® (ACT^®) System – the only FDA cleared device available that enables caregivers to proactively remove clots formed inside the chest tube to prevent or minimize chest tube occlusion with clot. A patent chest tube enables evacuation of blood and fluid from the operative site after closure of the surgical wound and reduces retained blood. Retained blood is accepted by physicians as contributing to many common complications after cardiac surgery, including post-operative atrial fibrillation (POAF), pleural effusions and pericardial effusions. PleuraFlow is used at the bedside in the ICU and enables caregivers to actively maintain chest tube patency following cardiac surgery.

The PleuraFlow ACT System is approved for use in the U.S., Europe, Australia, Brazil, Canada, Mexico and other countries in Asia and the Middle East.

About ClearFlow, Inc.

ClearFlow, Inc. is an Anaheim, CA based medical device company that has developed a patented active blood and fluid evacuation system to speed recovery, reduce complications and lower healthcare costs related to medical tube obstruction. The company has been awarded several prestigious awards, including the European Association of Cardiothoracic Surgeons Techno-College Innovation Award for a worldwide innovation that has the potential to change the standard of care in heart and lung surgery, and the Innovations in Cardiovascular Interventions Award, among others.